Published in Filaria J on October 24, 2003
Acaricidal effect and histological damage induced by Bacillus thuringiensis protein extracts on the mite Psoroptes cuniculi. Parasit Vectors (2015) 1.41
Nodding syndrome in Mundri county, South Sudan: environmental, nutritional and infectious factors. Afr Health Sci (2013) 1.20
Ivermectin reduces alcohol intake and preference in mice. Neuropharmacology (2012) 1.02
Ivermectin antagonizes ethanol inhibition in purinergic P2X4 receptors. J Pharmacol Exp Ther (2010) 1.01
Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg (2010) 0.94
The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis. PLoS Negl Trop Dis (2008) 0.82
Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas. Filaria J (2003) 0.82
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J (2017) 0.79
Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder. Neuropharmacology (2016) 0.75
Oral ivermectin as an unexpected initiator of CreT2-mediated deletion in T cells. Nat Immunol (2012) 0.75
Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers. BMC Pharmacol Toxicol (2017) 0.75
A bipolar disorder patient becoming asymptomatic after adjunctive anti-filiarasis treatment: a case report. BMC Psychiatry (2013) 0.75
P-Glycoprotein Transport of Neurotoxic Pesticides. J Pharmacol Exp Ther (2015) 0.75
Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial. JMIR Res Protoc (2017) 0.75
Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae. Sci Rep (2017) 0.75
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell (1994) 6.02
Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A (2000) 5.89
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet (1997) 4.98
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A (1989) 4.66
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest (1995) 3.13
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A (1997) 2.91
avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J (1997) 2.55
Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg (1998) 1.90
Clinical observations in collies given ivermectin orally. Am J Vet Res (1987) 1.83
Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics (2001) 1.58
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol (1999) 1.52
HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem Pharmacol (1999) 1.51
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology (2000) 1.42
Haemonchus contortus: ivermectin-induced paralysis of the pharynx. Exp Parasitol (1993) 1.22
Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization. J Biol Chem (1997) 1.20
Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J Histochem Cytochem (1999) 1.20
Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci (2000) 1.18
The biochemical basis of anthelmintic action and resistance. Int J Parasitol (2001) 1.17
Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica (2001) 1.14
Picrotoxin blockade of invertebrate glutamate-gated chloride channels: subunit dependence and evidence for binding within the pore. J Neurochem (1999) 1.12
Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. Am J Trop Med Hyg (1991) 1.03
Pharmacology of anthelmintic resistance. Parasitol Today (1999) 1.01
Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br J Clin Pharmacol (2000) 0.99
Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. Xenobiotica (1998) 0.99
Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun (1998) 0.98
An electrophysiological preparation of Ascaris suum pharyngeal muscle reveals a glutamate-gated chloride channel sensitive to the avermectin analogue, milbemycin D. Parasitology (1996) 0.97
Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol Appl Pharmacol (1997) 0.97
Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. Drug Metab Dispos (1999) 0.93
Ivermectin excretion by isolated functionally intact brain endothelial capillaries. Br J Pharmacol (2001) 0.92
Epithelial transport of anthelmintic ivermectin in a novel model of isolated proximal kidney tubules. Pharm Res (1999) 0.88
Characterization of efflux transport of organic anions in a mouse brain capillary endothelial cell line. J Pharmacol Exp Ther (1998) 0.87
Cyclosporin A and trifluoperazine, two resistance-modulating agents, increase ivermectin neurotoxicity in mice. Pharmacol Toxicol (1999) 0.85
The anthelminthic agent albendazole does not interact with p-glycoprotein. Drug Metab Dispos (2002) 0.83
Influence of antipsychotic, antiemetic, and Ca(2+) channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation. J Pharmacol Exp Ther (2000) 0.83
Changes in the use profile of Mectizan: 1987-1997. Ann Trop Med Parasitol (1998) 0.83
Benzimidazoles, potent anti-mitotic drugs: substrates for the P-glycoprotein transporter in multidrug-resistant cells. Biochem Pharmacol (1994) 0.82
Presystemic metabolism of albendazole: experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumen. Drug Metab Dispos (1999) 0.82
Molecular biology and electrophysiology of glutamate-gated chloride channels of invertebrates. Parasitology (1996) 0.82
Effects of macrocyclic lactones on ingestion in susceptible and resistant Haemonchus contortus larvae. J Parasitol (1998) 0.77